SCHEMBL6163418

SCHEMBL6163418

CN(C)c1cc2c(cc1-c1cccc(F)c1F)NC(=O)CC(c1cccc(-n3ccnn3)c1)=N2

nearest known ligand 0.72

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6167087 0.94 CYP3A4 (0.73) CYP3A4
SCHEMBL5869210 0.85 CYP3A4 (0.88) CYP3A4
SCHEMBL6164110 0.84 CYP3A4 (0.60) CYP3A4
SCHEMBL6164338 0.84 CYP3A4 (0.60) CYP3A4
SCHEMBL7140734 0.83 CYP3A4 (0.79) CYP3A4
SCHEMBL6167981 0.82 CYP3A4 (0.47) CYP3A4
SCHEMBL5869121 0.81 CYP3A4 (1.00) CYP3A4
SCHEMBL6167554 0.80
SCHEMBL6162516 0.79 CYP3A4 (0.57) CYP3A4
SCHEMBL7146606 0.79 CYP3A4 (0.70) CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1379511-B1 DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II HOFFMANN LA ROCHE (CH) 2005-07-20 EP disclosed
US-6544985-B2 For therapy of acute and/or chronic neurological disorders such as psychosis, schizophrenia, Alzheimer's disease, cognitive disorders and memory deficits HOFFMAN-LA ROCHE INC. 2003-04-08 US disclosed